New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients Notified - ---
M/Y Dagger joins the SEA Index®: HSH Prince Albert II discovers Benetti’s new hybrid yacht Notified -
Descartes Expands AI Innovation with Agent that Helps Reduce Global Trade Data Research and Analysis Time by Up to 90% Notified -
Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab) Notified -
Hong Kong Tourism Board Makes Monaco Yacht Show Debut to Showcase Ambition as Asia's Leading Yacht Tourism and Marine Business Hub Notified -
Schneider Electric unveils the world’s first fully Software-Defined Medium Voltage switchgear to accelerate the speed and scalability of AI factories Notified -
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition Notified -
Datalec Strengthens its Liquid Cooling Capabilities with the Appointment of Dominik Dziarczykowski Notified -